메뉴 건너뛰기




Volumn 3, Issue 4, 2002, Pages 279-284

Safety and tolerance of efavirenz in different antiretroviral regimens: Results from a national multicenter prospective study in 1,033 HIV-infected patients

Author keywords

Efavirenz; Pharmacosurveillance; Side effects

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; METHADONE; NELFINAVIR; NEVIRAPINE; PSYCHOTROPIC AGENT; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; OXAZINE DERIVATIVE;

EID: 0035986092     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/3q91-yt2d-but4-8hn6     Document Type: Article
Times cited : (101)

References (23)
  • 5
    • 0035822951 scopus 로고    scopus 로고
    • Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz
    • (2001) AIDS , vol.15 , pp. 1679-1686
    • Lucas, G.M.1    Chaisson, R.E.2    Moore, R.D.3
  • 8
    • 0011015626 scopus 로고    scopus 로고
    • Successful substitution of protease inhibitors with efavirenz (EFV) in patients with undetectable viral loads-a prospective, randomized, multicenter, open-label study (DMP 049)
    • Program and abstracts of the First International AIDS Society Conference on HIV Pathogenesis and Treatment; July 8-11, Buenos Aires, Argentina. Abstract 812
    • (2001)
    • Rachlis, A.1    Becker, S.2    Gill, J.3
  • 10
    • 0009771296 scopus 로고    scopus 로고
    • 3-year durability of response with an efavirenz (EFV)-containing regimen: 144-week follow-up of Study 006
    • Program and abstracts of the First International AIDS Society Conference on HIV Pathogenesis and Treatment; July 8-11, Buenos Aires, Argentina. Abstract 810
    • (2001)
    • Tashima, K.1    Staszewski, S.2    Morales-Ramirez, J.3
  • 13
    • 0009771828 scopus 로고    scopus 로고
    • Department; of Human Services (DHHS) and the Henry J. Kaiser Family Foundation Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. www.hivatis.org
    • (2001)
  • 16
    • 0009808534 scopus 로고    scopus 로고
    • Efficacy and safety of sustiva (efavirenz) in the French TAU (Temporary Authorization for Use): A programme providing rapid access to drugs prior to registration
    • Program and abstracts of the 13th International AIDS Conference; July 9-14, Durban, South Africa. Abstract ThPeB5272
    • (2000)
    • Gregoire, V.1    Mariot, P.2
  • 19
    • 0009795874 scopus 로고    scopus 로고
    • Ficha técnica de Efavirenz. Stevenage, Hertfordshire: DuPont Pharmaceuticals Limited. Reino Unido; October
    • (2000)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.